NCT05831137 is a NA clinical trial of shorter cryoanalgesia in Funnel Chest, sponsored by Pomeranian Medical University Szczecin.

Who is sponsoring NCT05831137?

NCT05831137 is sponsored by Pomeranian Medical University Szczecin.

What drugs are being tested in NCT05831137?

Interventions in NCT05831137: shorter cryoanalgesia.

What condition does NCT05831137 study?

NCT05831137 studies Funnel Chest, Excavatum, Pectus.

Is NCT05831137 still recruiting?

NCT05831137 is currently status unknown. Last updated 26 April 2023.

Last reviewed 2023-04-26 · How we verify

NCT05831137

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cryoanalgesia Aplication Time Optimization During Nuss Procedure

Status unknown NA Last updated 26 April 2023

What this trial tests

NA trial testing shorter cryoanalgesia in Funnel Chest in 20 participants. Status unknown.

Timeline

31 March 2023

Primary endpoint
10 June 2023

10 July 2023

Quick facts

Lead sponsor	Pomeranian Medical University Szczecin
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	31 March 2023
Primary completion	10 June 2023
Estimated completion	10 July 2023
Sites	1 location across Poland

Drugs / interventions tested

shorter cryoanalgesia

Conditions studied

Funnel Chest — all drugs for Funnel Chest →
Excavatum, Pectus — all drugs for Excavatum, Pectus →

Sponsor

Pomeranian Medical University Szczecin

Who can join

10 and older, any sex, with Funnel Chest or Excavatum, Pectus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compared standard therapy (multimodal analgesia with 2 minutes cryoanalgesia) versus a novel approach (multimodal analgesia with 1 minute cryoanalgesia) in subject undergoing minimal invasive modyfied Nuss procedure with thoracoscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Pomeranian Medical University Szczecin trials

Trials by the same sponsor.

NCT07370649 — Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study · not yet recruiting
NCT07328789 — Factors Influencing Cardiac Rehabilitation Success · not yet recruiting
NCT06809101 — Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Bal · recruiting
NCT07070609 — Sagittal Spine Balance in Patients With Chest Wall Deformity · active not recruiting
NCT06743360 — Microanalysis of Changes in 3D Geometry of Orthodontic Mini-implants · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05831137 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pomeranian Medical University Szczecin
Last refreshed: 26 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05831137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing